COMP <GO>
VAL vs CVX // RSI-14 & 200D SMA MOMENTUM
Valaris Limited (NYSE) VS. Chevron Corporation (NYSE) • 15-METRIC TALLY: VAL 7
— CVX 5
▲ RSI-14 & 200D SMA MOMENTUM LEADER: VAL
LAST: $105.31 (+3.54%) • MKT CAP: $7.06B
rsi-technicals
79.3
LAST: $235.52 (+1.75%) • MKT CAP: $457.31B
rsi-technicals
72.8
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VAL VS. CVX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VAL | CVX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | -30.00% | 41.30% | -71.30 | CVX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 10.30% | 5.80% | +4.50 | VAL | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.8x | 21.5x | -11.70 | VAL | /valuation <GO> |
| Free Cash Flow Yield | 2.87% | 5.61% | -2.74 | CVX | /fcf-yield <GO> |
| Operating Margin | 75.00% | 8.10% | +66.90 | VAL | /operating-margins <GO> |
| Net Profit Margin | 68.00% | 6.70% | +61.30 | VAL | /net-margins <GO> |
| Revenue Growth (YoY) | 24.00% | -4.60% | +28.60 | VAL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.79% | -2.79 | CVX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.03 | 3.71 | -0.68 | CVX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 7.10% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 79.3 | 72.8 | +6.46 | VAL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.07 | 1.07 | 0.00 | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 6.0x | 34.6x | -28.60 | VAL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.06B | $457.31B | -$450.25B | CVX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VAL REV | CVX REV | VAL GROSS % | CVX GROSS % | VAL FCF | CVX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $11.9M | $184.43B | -13595.0% | 41.3% | $202.7M | $25.64B |
| FY 2024 | $9.6M | $193.41B | -18242.7% | 38.4% | -$99.7M | $22.79B |
| FY 2023 | $8.4M | $196.91B | 44.0% | 44.0% | $267.1M | $26.75B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VAL // BETA 1.07
CVX // BETA 1.07